Skip to content
10-Q

Quarterly Report

Advanced BioMedical Technologies, Inc.

0001493152-21-022511

← back to feed
Filed
Sep 13, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2021 · Sep 13, 2021 70.22M sh
Shares Diluted Q3 2021 · Jul 31, 2021 70.46M sh
Shares Diluted Q3 2021 · Jul 31, 2021 70.46M sh
Shares Diluted Q3 2021 · Jul 31, 2020 70.21M sh
Shares Diluted Q3 2021 · Jul 31, 2020 70.06M sh
Capex Q3 2021 · Jul 31, 2021 $51.45K
Capex Q3 2021 · Jul 31, 2020 $29.69K
Operating Cash Flow Q3 2021 · Jul 31, 2021 −$743.04K
Operating Cash Flow Q3 2021 · Jul 31, 2020 −$105.51K
Cash And Equivalents Q3 2021 · Jul 31, 2021 $6.98K
Cash And Equivalents Q3 2021 · Oct 31, 2020 $201.66K
Stockholders Equity Q3 2021 · Jul 31, 2021 −$8.18M
Stockholders Equity Q3 2021 · Apr 30, 2021 −$7.97M
Stockholders Equity Q3 2021 · Jan 31, 2021 −$7.83M
Stockholders Equity Q3 2021 · Oct 31, 2020 −$7.4M
Stockholders Equity Q3 2021 · Jul 31, 2020 −$6.99M
Stockholders Equity Q3 2021 · Apr 30, 2020 −$6.72M
Stockholders Equity Q3 2021 · Jan 31, 2020 −$6.64M
Stockholders Equity Q3 2021 · Oct 31, 2019 −$6.48M
Current Liabilities Q3 2021 · Jul 31, 2021 $8.58M
Current Liabilities Q3 2021 · Oct 31, 2020 $7.86M
Current Assets Q3 2021 · Jul 31, 2021 $242.57K
Current Assets Q3 2021 · Oct 31, 2020 $330.95K
Total Assets Q3 2021 · Jul 31, 2021 $396.51K
Total Assets Q3 2021 · Oct 31, 2020 $469.23K
Sga Expense Q3 2021 · Jul 31, 2021 $54.43K
Sga Expense Q3 2021 · Jul 31, 2021 $137.26K
Sga Expense Q3 2021 · Jul 31, 2020 $54.77K
Sga Expense Q3 2021 · Jul 31, 2020 $166.83K
Rd Expense Q3 2021 · Jul 31, 2021 $54.63K
Rd Expense Q3 2021 · Jul 31, 2021 $178.09K
Rd Expense Q3 2021 · Jul 31, 2020 $42.77K
Rd Expense Q3 2021 · Jul 31, 2020 $140.86K
Net Income Q3 2021 · Jul 31, 2021 −$198.71K
Net Income Q3 2021 · Jul 31, 2021 −$559.85K
Net Income Q3 2021 · Apr 30, 2021 −$189.09K
Net Income Q3 2021 · Jan 31, 2021 −$172.04K
Net Income Q3 2021 · Jul 31, 2020 −$205.23K
Net Income Q3 2021 · Jul 31, 2020 −$478.67K
Net Income Q3 2021 · Apr 30, 2020 −$209.65K
Net Income Q3 2021 · Jan 31, 2020 −$63.79K
Operating Income Q3 2021 · Jul 31, 2021 −$111.77K
Operating Income Q3 2021 · Jul 31, 2021 −$313.56K
Operating Income Q3 2021 · Jul 31, 2020 −$116.44K
Operating Income Q3 2021 · Jul 31, 2020 −$336.42K
Gross Profit Q3 2021 · Jul 31, 2021 $142
Gross Profit Q3 2021 · Jul 31, 2021 $37.29K
Gross Profit Q3 2021 · Jul 31, 2020 $141
Gross Profit Q3 2021 · Jul 31, 2020 $27.42K
Revenue Q3 2021 · Jul 31, 2021 $180
Revenue Q3 2021 · Jul 31, 2021 $47.51K
Revenue Q3 2021 · Jul 31, 2020 $961
Revenue Q3 2021 · Jul 31, 2020 $61.25K